先進(3D/4D)視覚化システムの世界市場

◆英語タイトル:Global Advanced (3D/4D) Visualization Systems Industry

Global Industry Analystsが発行した調査報告書(GIA21AP105)◆商品コード:GIA21AP105
◆発行会社(リサーチ会社):Global Industry Analysts
◆発行日:2021年4月
◆ページ数:286
◆レポート形式:英語 / PDF(印刷不可)
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:電子
◆販売価格オプション(消費税別)
Single UserUSD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Five UserUSD7,840 ⇒換算¥1,160,320見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Advanced (3D/4D) Visualization Systems Market to Reach $4.1 Billion by 2027- Amid the COVID-19 crisis, the global market for Advanced (3D/4D) Visualization Systems estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$4.1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. MRI, one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrasound segment is readjusted to a revised 7.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $717.6 Million, While China is Forecast to Grow at 10.1% CAGR
- The Advanced (3D/4D) Visualization Systems market in the U.S. is estimated at US$717.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$913.2 Million by the year 2027 trailing a CAGR of 10.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
- Radio Therapy Segment to Record 5.8% CAGR
- In the global Radio Therapy segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$217.7 Million in the year 2020 will reach a projected size of US$313.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$558.9 Million by the year 2027, while Latin America will expand at a 6.9% CAGR through the analysis period.

- Select Competitors (Total 37 Featured) -
Agfa-Gevaert Group
Canon Medical Systems USA Inc.
Carestream Health, Inc.
CONMED Corporation
EOS Imaging
Fujifilm Holding America Corporation
GE Healthcare
Hitachi High-Technologies Corporation
Koninklijke Philips N.V.
Siemens AG
TeraRecon, Inc.
Thermo Fischer Scientific Inc.
TrueVision Systems, Inc.
Visage Imaging, Inc.
Vital Images, Inc.
Ziosoft

❖ レポートの目次 ❖

I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
As An Indispensable Element in Medical Practice, Imaging Continues to Evolve Providing the Cornerstone for the Growth of 3D/4D Visualization Systems
Recent Market Activity
Chronic Diseases & Aging Population Stretch Healthcare Resources Including Demand for Medical Imaging
Market Outlook
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Agfa-Gevaert Group (USA)
Canon Medical Systems USA Inc. (USA)
Carestream Health, Inc. (USA)
CONMED Corporation (USA)
Fujifilm Holding America Corporation (USA)
EOS Imaging (France)
GE Healthcare (UK)
Hitachi High-Technologies Corporation (Japan)
Koninklijke Philips N.V. (The Netherlands)
Siemens AG (Germany)
TeraRecon, Inc. (USA)
Thermo Fisher Scientific (USA)
TrueVision Systems, Inc. (USA)
Visage Imaging, Inc. (USA)
Vital Images, Inc. (USA)
Ziosoft (USA)
3. MARKET TRENDS & DRIVERS
Rise in Image Guided Surgeries Drives Demand for 3D/4D Imaging Systems &Visualization Tools
Rise of Telesurgery, a Revenue Spinning Trend in the Market
Epidemic Spread of Cancer Drives Interest in 4D Radiation Therapy (4DRT) Enabled by 4D Visualization Systems
Demand for Advanced Visualization Methods in Clinical Radiology Spurs Integration of 3D & 4D Visualization Tools with PACS
3D Image Sensors & 3D Displays: Vital Elements in Advanced 3D Visualization Systems
Collaborative Evaluation of 3D MRI, CT & Ultrasonic Imaging Data Strengthens the Business Case for Advanced Visualization Technologies
Developments in Interactive 3D Image Segmentation to Benefit Growth in the Market
Expanding Applications in Cardiology, Neurology Dentistry, Orthopedics & Gynecology
Advanced 3D/4D Visualization System Enhances Diagnostic Skill Acquisition and Supports Tactile Learning in Medical Training
Thin Client: The New Standard in Advanced Visualization
5D Imaging: Is it a Threat for 3D & 4D Visualization Software?
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Advanced (3D/4D) Visualization Systems by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for MRI by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for MRI by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for MRI by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Ultrasound by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Ultrasound by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Ultrasound by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Radio Therapy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Radio Therapy by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Radio Therapy by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for CT by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for CT by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for CT by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for PET by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for PET by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for PET by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Nuclear Medicine by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Nuclear Medicine by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Nuclear Medicine by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Other Modalities by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Other Modalities by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Other Modalities by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 25: World Current & Future Analysis for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 28: World Current & Future Analysis for Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Diagnostic Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 31: World Current & Future Analysis for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other End-Uses by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Other End-Uses by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 34: USA Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 35: USA Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: USA 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 37: USA Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 38: USA Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: USA 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
TABLE 40: Canada Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 43: Canada Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 44: Canada Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 45: Canada 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
TABLE 46: Japan Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 49: Japan Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
TABLE 52: China Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 53: China Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 54: China 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 55: China Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
TABLE 58: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 59: Europe Historic Review for Advanced (3D/4D) Visualization Systems by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 60: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 61: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 62: Europe Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 63: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 64: Europe Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
TABLE 67: France Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 68: France Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 69: France 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 70: France Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 71: France Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 72: France 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
TABLE 73: Germany Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 74: Germany Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 75: Germany 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 76: Germany Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 77: Germany Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 78: Germany 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
TABLE 79: Italy Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 80: Italy Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 81: Italy 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 82: Italy Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 83: Italy Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 84: Italy 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 85: UK Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 86: UK Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 87: UK 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 88: UK Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 89: UK Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 90: UK 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
SPAIN
TABLE 91: Spain Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 92: Spain Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 93: Spain 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 94: Spain Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 95: Spain Historic Review for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 96: Spain 15-Year Perspective for Advanced (3D/4D) Visualization Systems by End-Use – Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
RUSSIA
TABLE 97: Russia Current & Future Analysis for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 98: Russia Historic Review for Advanced (3D/4D) Visualization Systems by Modality – MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 99: Russia 15-Year Perspective for Advanced (3D/4D) Visualization Systems by Modality – Percentage Breakdown of Value Sales for MRI, Ultrasound, Radio Therapy, CT, PET, Nuclear Medicine and Other Modalities for the Years 2012, 2020 & 2027
TABLE 100: Russia Current & Future Analysis for Advanced (3D/4D) Visualization Systems by End-Use – Hospitals, Diagnostic Centers and Other End-Uses – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 先進(3D/4D)視覚化システムの世界市場(Global Advanced (3D/4D) Visualization Systems Industry)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆